Aligos Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.44

+0.41 (+6.80%)

As of May 16, 2:21 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target -3.9% upside

Low Target $4.22

Average Target $6.19

High Target $8.57

Current Price $6.44

Current
$6.44

Target
$6.19

$4.22 $6.19 avg $8.57

Scenario Analysis

Bear Case

$4.22

-34.5%

Low target

Base Case

$6.19

-3.9%

Avg target

Bull Case

$8.57

+33.1%

High target

Risk/Reward

1.0x

Unfavorable

Price in Context

52-Week High

$13.69

-53.0% from high

52-Week Low

$5.12

+25.8% from low

Target vs 52W High

$6.19

-54.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%